BIZTRAC BETA
Retail sale of pharmaceutical products

APOTERA.NO AS

Org. no. 924572051 Limited company (AS) Oslo Incorporated 2020 Active
Ownership graph ↗
Revenue 2024 NOK 136.1m
Operating profit NOK −2.7m
Equity NOK 6.2m
Incorporated 2020
Employees 38
Share capital NOK 90,000

Signals

1 flags
  • Driftsunderskudd 2024 Siste driftsresultat er negativt (−2,7 mill kr).

APOTERA.NO AS is registered as a limited company in Oslo, Oslo with organisation number 924572051. The business is classified under retail sale of pharmaceutical products (NACE 47.730). The company was incorporated in 2020 and has 38 registered employees. Registered share capital is NOK 90,000, divided into 3006638 shares. The company's stated purpose is: “Apotekvirksomhet med eget utsalg og ved salg av apotekvarer via internett samt all virksomhet som står i forbindelse med dette, herunder det å eie aksjer i andre selskaper med samme formål eller selskaper i tilsvarende bransje.”. The most recent filed accounts, for the 2024 financial year, show NOK 136.1m in revenue and NOK −2.7m in operating profit.

Key figures · 2024

Revenue
NOK 136.1m
Operating profit
NOK −2.7m
Equity
NOK 6.2m
Est. value
NOK 47.2m

Financial health · 2024

Liquidity
1.11
Satisfactory
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
27.0%
Good
Equity as a share of total capital

Who owns APOTERA.NO AS?

APOTEA AB
APOTERA.NO AS
NOK 136.1m rev. · NOK −2.7m profit

APOTERA.NO AS has 8 registered shareholders:

All shareholders and roles →

Frequently asked questions about APOTERA.NO AS

Who owns APOTERA.NO AS?

APOTEA AB is the largest registered owner, with 56.8%.

What is the revenue of APOTERA.NO AS?

APOTERA.NO AS had revenue of NOK 136.1m in 2024.

Where is APOTERA.NO AS based?

APOTERA.NO AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.